Action 1302 LIFETECH SCIENTIFIC CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues LifeTech Scientific Corporation

Actions

1302

KYG548721177

Marché Fermé - Hong Kong S.E.
Autres places de cotation
 10:09:00 03/05/2024 		Varia. 5j. Varia. 1 janv.
1,7 HKD -5,03 % Graphique intraday de LifeTech Scientific Corporation +5,59 % -27,66 %
11/04 Lifetech Scientific achète des actions pour le plan d'incitation des employés MT
04/04 Une unité de Lifetech Scientific investit 340 millions de yuans dans des dépôts structurés MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Lifetech Scientific Buys Shares For Employee Incentive Scheme
Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits
LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development
Lifetech Scientific Books Lower 2023 Profit Despite Surge in Revenue
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
LifeTech Scientific Flags Significant Profit Drop in 2023
Lifetech Scientific Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
LifeTech Scientific to Grant 174.8 Million Share Options
LifeTech Scientific Gets Regulatory Nod to Register Peripheral Thrombus Aspiration Catheter
LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results
LifeTech Scientific's H1 Attributable Profit Grows on Higher Revenue
LifeTech Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
China Grants Official Registration Approval for LifeTech Scientific's Surgical Navigation System
Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA
Jenscare Scientific, LifeTech Complete Treatment for Valve Replacement Product; Jenscare Shares Rise 3%
LifeTech Scientific Unit Invests 50 Million Yuan in Structured Deposit Product by Bank of Ningbo
LifeTech Scientific Completes Patient Enrollment for Phase 3 Study of Coronary Scaffold System
Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of Ibs®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
LifeTech Scientific Corporation Announces Publication of the Three-Year Follow-Up Results of FIM Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 1302
  4. Actualités LifeTech Scientific Corporation
  5. Autres langues